Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on cardiovascular events.
Source: medscape.com
Profile Improved News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Profile Improved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Profile Improved Today - Breaking & Trending Today